Where herbal tradition meets modern research.
Our research team brings decades of experience in herbal pharmacology, molecular biology, extraction processes and data analytics.
A connected process, start to finish.
Each phase, from research through distribution, is linked to real-time insights from healthcare providers.
Gathering insights
Anonymized usage trends and provider feedback shape formulation goals.
Manufacturer collaboration
Exact specifications go to cGMP-compliant contract manufacturers.
Quality control
Every batch is sample-tested for quality, safety and labeling.
Distribution
Inventory and logistics data flow into DirectCM in real time.
Iteration
Ongoing feedback guides further product enhancements.
Self-affirmed GRAS conclusions.
With independent toxicologists and in accordance with FDA guidance, we have reached self-affirmed GRAS conclusions for the principal botanical ingredients in our BioPrecision line.
- Notoginseng (Panax notoginseng) saponin extract
- Breviscapine (Erigeron breviscapus) flavonoid extract
- Polygonum capitatum extract
- Innerpure formulation
- Rodgersia sambucifolia Hemsl. extract
The FDA does not approve GRAS status and has not reviewed these conclusions.
Research with integrity.
We fund voluntary, preclinical and exploratory research with independent research institutions to evaluate the safety and potential wellness benefits of the botanicals we use.
- Informed consent and IRB review under 21 C.F.R. Parts 50 and 56 where human participants are involved.
- Good Clinical Practice guidelines and applicable state requirements.
- Fully self-funded through our internal R&D budget.
Studies focus on tolerability, dosage and structure or function outcomes. They are not designed to demonstrate the treatment, cure, mitigation or prevention of any disease.
Science you can see in every formulation.
Discover the products our research supports.